FI120039B - Stabil vattenhaltig folinatlösning - Google Patents

Stabil vattenhaltig folinatlösning Download PDF

Info

Publication number
FI120039B
FI120039B FI963972A FI963972A FI120039B FI 120039 B FI120039 B FI 120039B FI 963972 A FI963972 A FI 963972A FI 963972 A FI963972 A FI 963972A FI 120039 B FI120039 B FI 120039B
Authority
FI
Finland
Prior art keywords
solution
sodium
folinate
aqueous
injection
Prior art date
Application number
FI963972A
Other languages
English (en)
Finnish (fi)
Other versions
FI963972A0 (sv
FI963972A (sv
Inventor
Alfred James Nijkerk
Johanna Maria Pieterne Vermeer
Original Assignee
Pharmachemie Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmachemie Bv filed Critical Pharmachemie Bv
Publication of FI963972A0 publication Critical patent/FI963972A0/sv
Publication of FI963972A publication Critical patent/FI963972A/sv
Application granted granted Critical
Publication of FI120039B publication Critical patent/FI120039B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D475/00Heterocyclic compounds containing pteridine ring systems
    • C07D475/02Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Claims (6)

1. Va 1tenhal tig nati'iumfo Iinat loaning för f arma-ceutiska tillämpningar, väri haiten av natriumfolinat är 5 högst 400 mg, beräknat som folinsyra, per milliliter och nämnda lösnings pH är i omrädet 4,0 - 10,0 och den inne-haller dessuborn ett stabiliseringsmedel, som väljs f rän natriumcitrat och nati'iumacetat, med undantag av lösning-ar, där haiten av natriumfolinat är högst 15 mg/ml.
2. Vattenhaltig folinatlösning enligt patentkrav 1, kanne t e cknad av att lösningens pH är cirka 6,0 - 10,0.
3. Vattenhaltig folinatlösning enligt patentkrav 1 eller 2, kännetecknad av att lösningens pH är cirka 15 8,0-9,0.
4. Vattenhaltig folinatlösning enligt ett eller flera av patentkraven 1 - 3, kännetecknad av att nämndä löshing ocksä omfattar ett isotoniserande medel.
5. Vattenhaltig folinatlösning enligt patentkrav 2 0 4, kännetecknad av att nämnda isotoniserande medel är natriumklorid.
6. Vattenhaltig folinatlösning enligt ett eller flera av patentkraven 1-5, kännetecknad av att nämnda lösning ocksä omfattar en farmaceutiskt godtagbar 25 buffert f rän gruppen bestäende av tris-, fosfat- och kar-bönatbuf fertmaterlai.
FI963972A 1994-04-05 1996-10-03 Stabil vattenhaltig folinatlösning FI120039B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
NL9400530A NL9400530A (nl) 1994-04-05 1994-04-05 Stabiele waterige folinaatoplossing.
NL9400530 1994-04-05
PCT/NL1995/000126 WO1995026963A1 (en) 1994-04-05 1995-04-04 Stable aqueous folinate solution
NL9500126 1995-04-04

Publications (3)

Publication Number Publication Date
FI963972A0 FI963972A0 (sv) 1996-10-03
FI963972A FI963972A (sv) 1996-10-03
FI120039B true FI120039B (sv) 2009-06-15

Family

ID=19864026

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963972A FI120039B (sv) 1994-04-05 1996-10-03 Stabil vattenhaltig folinatlösning

Country Status (15)

Country Link
US (1) US6613767B1 (sv)
EP (1) EP0755396B1 (sv)
JP (1) JPH09510989A (sv)
AT (1) ATE194346T1 (sv)
AU (1) AU684350B2 (sv)
DE (1) DE69517806T2 (sv)
DK (1) DK0755396T3 (sv)
ES (1) ES2149354T3 (sv)
FI (1) FI120039B (sv)
GR (1) GR3033863T3 (sv)
NL (1) NL9400530A (sv)
NO (1) NO314039B1 (sv)
PT (1) PT755396E (sv)
WO (1) WO1995026963A1 (sv)
ZA (1) ZA952805B (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH687062A5 (de) * 1994-02-14 1996-09-13 Cerbios Pharma Sa Konzentrierte Injektionsloesung von Alkalimetallsalzen von reduzierten Folaten.
NL9400530A (nl) 1994-04-05 1995-11-01 Pharmachemie Bv Stabiele waterige folinaatoplossing.
CH697021A5 (de) * 2003-06-26 2008-03-31 Merck Eprova Ag Stabile pharmazeutische Zusammensetzungen von 5, 10-Methylentetrahydrofolat.
CH696717A5 (de) * 2004-02-20 2007-10-31 Cerbios Pharma Sa Konzentrierte, stabile Losung, insbesondere eine Injektionslosung oder Infusionslosung, welche nebst Wasser entweder (6S)-Natrium-Folinat oder (6S)-Kalium-Folinat entholt
CN102258463A (zh) * 2011-07-18 2011-11-30 重庆煜澍丰医药有限公司 一种稳定的亚叶酸钠注射液
ES2414557B1 (es) * 2012-01-16 2014-06-10 Novocat Farma, S.A. Composición acuosa de paracetamol para inyección
WO2014025807A1 (en) 2012-08-06 2014-02-13 Spectrum Pharmaceuticals, Inc. Pharmaceutical compositions comprising l-leucovorin
US10059710B2 (en) 2016-02-17 2018-08-28 Merck & Cie Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2695860A (en) * 1952-04-29 1954-11-30 American Cyanamid Co Stabilized pteroyl solutions
CH673459A5 (sv) 1987-05-15 1990-03-15 Eprova Ag
WO1990010460A1 (en) 1989-03-13 1990-09-20 Kenneth Naoyuki Matsumura Method for reducing side effects of a drug
NL8901432A (nl) * 1989-06-06 1991-01-02 Pharmachemie Bv Bij koelkasttemperatuur stabiele waterige folinaatoplossing, alsmede werkwijze ter bereiding daarvan.
US5173488A (en) * 1989-08-21 1992-12-22 American Cyanamid Company Stable injectable pharmaceutical formulation for folic acid and leucovorin salts and method
CH687062A5 (de) 1994-02-14 1996-09-13 Cerbios Pharma Sa Konzentrierte Injektionsloesung von Alkalimetallsalzen von reduzierten Folaten.
NL9400530A (nl) 1994-04-05 1995-11-01 Pharmachemie Bv Stabiele waterige folinaatoplossing.

Also Published As

Publication number Publication date
EP0755396A1 (en) 1997-01-29
JPH09510989A (ja) 1997-11-04
NL9400530A (nl) 1995-11-01
FI963972A0 (sv) 1996-10-03
PT755396E (pt) 2000-10-31
EP0755396B1 (en) 2000-07-05
FI963972A (sv) 1996-10-03
DE69517806T2 (de) 2001-11-08
NO314039B1 (no) 2003-01-20
GR3033863T3 (en) 2000-10-31
AU2086295A (en) 1995-10-23
ES2149354T3 (es) 2000-11-01
DE69517806D1 (de) 2000-08-10
ZA952805B (en) 1995-12-19
NO964231D0 (no) 1996-10-04
ATE194346T1 (de) 2000-07-15
NO964231L (no) 1996-10-04
AU684350B2 (en) 1997-12-11
WO1995026963A1 (en) 1995-10-12
DK0755396T3 (da) 2000-11-13
US6613767B1 (en) 2003-09-02

Similar Documents

Publication Publication Date Title
US4931441A (en) Stabilized aqueous leucovorin calcium compositions
US5177076A (en) Aqueous folinate solution stable at refrigerator temperature, as well as process for its preparation
US5210083A (en) Pharmaceutical compositions
KR950703988A (ko) 긴 보장기간을 갖는 g-csf의 수성 약제 조성물(aqueous pharmaceutical preparations of g-csf whth a long shelf life)
FI120039B (sv) Stabil vattenhaltig folinatlösning
CA1052270A (en) Oxytetracycline solution for parenteral peroral and local administration and processes for the production thereof
EP0253662B1 (en) Pharmaceutical compositions
FI87993C (sv) Förfarande för framställning av alkaliska injektionslösningar av toras emid innehållande vatten, som är färdiga för injicering
US4931442A (en) Stabilized aqueous folic acid preparation
EP1327453B1 (en) Stable taurolidine electrolyte solutions
RU2002116364A (ru) Композиция альфа-интерферона в форме водного раствора
CA1183086A (en) Antimicrobial preparation
CN102573828A (zh) 通过施用肌酸化合物的透析患者中的细胞保护
US2407412A (en) Therapeutic solutions
US6143795A (en) Stable mitoxantrone solutions
CA2187186C (en) Stable aqueous folinate solution
US2719812A (en) Stabilized aqueous solutions of streptomycin
US4579960A (en) Stable solutions containing thimerosal
US4645670A (en) Process for the stabilization of hematin
JP3208166B2 (ja) アミノ酸含有輸液の安定化方法
US2191118A (en) Pyelographic preparation
WO1991016913A1 (en) Stabilized heparin solution

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 120039

Country of ref document: FI

MA Patent expired